Correlation between omental TNF-α protein and plasma PAI-1 in obesity subjects

被引:12
|
作者
Cao, Yan Li [1 ]
Wang, Yu Xia [2 ]
Wang, Di Fei [1 ]
Meng, Xin [1 ]
Zhang, Jin [1 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Affiliated Hosp 4, Dept Endocrinol, Shenyang 110032, Liaoning, Peoples R China
关键词
tumor necrosis factor-alpha; obesity; plasminogen activator inhibitor 1; omentum; vascular diseases;
D O I
10.1016/j.ijcard.2007.05.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The role of TNF-alpha in contributing to obesity-associated cardiovascular and metabolic risk has gained much attention. Materials and methods: Paired biopsies of omental and subcutaneous fat were collected from 16 lean subjects and 32 central obesity subjects. The expression of TNF-alpha in omental and subcutaneous fat was quantified by western blotting method, and correlations with plasma PAI-1, homeostasis model assessment insulin resistance (HOMA-IR), and lipid were investigated. Results: In obese female, TNF-alpha expression was higher in the omental than in the subcutaneous fat tissue. There was no significant difference in the levels of TNF-alpha between subcutaneous and visceral fat in obese male. Significant positive correlations were found between omental TNF-alpha protein and plasma PAI-1 levels in obesity. In obese female subjects, omental TNF-alpha protein levels showed a close association with most of the parameters studied: fasting glucose (r=0.541, P<0.05); fasting insulin (r=0.599, P<0.01); HOMA-IR (r=0.546, P<0.05); triglycerides (r=0.469, P<0.05); HDL-cholesterol (r=-0.759, P<0.01). In obese male population, correlations between omental TNF-alpha protein levels and fasting glucose (r=0.762, P<0.01); fasting insulin (r=0.622, P<0.05); triglycerides (r=0.650, P<0.05); HDL-cholesterol (r=-0.880, P<0.01) were found. Conclusion: Omental TNF-alpha may play a key role in contributing to cardiovascular risk in central obesity subjects. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 50 条
  • [41] PAI-1, obesity, insulin resistance and risk of cardiovascular events
    JuhanVague, I
    Alessi, MC
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (01) : 656 - 660
  • [42] PAI-1 and α2-AP in Patients with Morbid Obesity
    Michalska, Malgorzata
    Iwan-Zietek, Iza
    Gnilka, Wlodzimierz
    Dabrowiecki, Stanislaw
    Goralczyk, Barbara
    Goralczyk, Krzysztof
    Drela, Ewelina
    Rosc, Danuta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 22 (06): : 801 - 807
  • [43] NO EFFECT OF ASPIRIN ON CIRCULATING PAI-1 ANTIGEN IN PLASMA
    COGO, A
    LING, E
    LENSING, AWA
    STURK, A
    TENCATE, JW
    PRANDONI, P
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 393 - 393
  • [44] Role of PAI-1 in adipose tissue senescence and inflammation in obesity
    XU Jin
    GAO Qian
    吴剑波
    西南医科大学学报, 2021, 44 (05) : 439 - 444
  • [45] Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: Relation to polymorphisms of PAI-1 and angiotensin converting enzyme (ACE) genes
    Margaglione, M
    Grandone, E
    Vecchione, G
    Cappucci, G
    Giuliani, N
    Colaizzo, D
    Celentano, E
    Panico, S
    DiMinno, G
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) : 2082 - 2087
  • [46] Macrophage-derived PAI-1 influences the development of obesity
    De Taeye, B
    Bloodworth, J
    Vaughan, D
    OBESITY RESEARCH, 2005, 13 : A20 - A21
  • [47] The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals
    Verschuur, M
    Jellema, A
    Bladbjerg, EM
    Feskens, EJM
    Mensink, RP
    Moller, L
    Vos, HL
    de Maat, MPM
    ATHEROSCLEROSIS, 2005, 181 (02) : 275 - 284
  • [48] PAI-1 4G/5G polymorphism and PAI-1 plasma levels in ischemic stroke
    De Lucia, D
    Del Giudice, V
    Maisto, G
    De Francesco, F
    Fratta, M
    Quarantiello, M
    Caiazzo, P
    Papa, ML
    Margaglione, M
    Toso, V
    Majello, L
    Santangelo, R
    De Falco, FA
    NEUROLOGY, 2001, 56 (08) : A168 - A169
  • [49] The influence of residual platelets on plasma PAI-1 assays
    Barnard, S.
    Pieters, M.
    Loots, D. T.
    Rijken, D. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 339 - 339
  • [50] A novel solution phase PAI-1/uPA-biotin complex assay for the measurement of active PAI-1 in plasma
    Ma, Zhengping
    Cheng, Dong
    ANALYTICAL BIOCHEMISTRY, 2018, 563 : 35 - 39